NCT07621575

Brief Summary

The aim of the study is to compare between active drainage and passive drainage in post-operative seroma formation after modified radical mastectomy in female patient with breast carcinoma as regard of: Primary Outcomes:

  • Group A: Active drainage group (50 patients).
  • Group B: Passive drainage group (50 patients). After MRM ,drain output was measured daily using a graduated jar by nurse during hospital stay which was a one to two days in an average and then by patient himself. All the data was recorded on a paper sheet. In passive drain, breast and axilla outcomes were combined together as one read to be equal to one active drain gar. Twice per week, I checked this reading by myself and reported any complications).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
157

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 30, 2024

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 10, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 15, 2025

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

May 7, 2026

Completed
26 days until next milestone

First Posted

Study publicly available on registry

June 2, 2026

Completed
Last Updated

June 2, 2026

Status Verified

May 1, 2026

Enrollment Period

12 months

First QC Date

May 7, 2026

Last Update Submit

May 29, 2026

Conditions

Keywords

active Vs passive /MRM/suction drain

Outcome Measures

Primary Outcomes (1)

  • Daily drain output (mL/day)

    amount of drain output (mL/day)

    7 weeks for each case

Secondary Outcomes (5)

  • Duration of the drain in place (in days)

    7 weeks for each case

  • Amount of seroma aspiration after the drain removal (mL)

    7 weeks for each case

  • Number of days till the last seroma aspiration (in days)

    7 weeks for each case

  • Flap necrosis

    7 weeks for each case

  • Surgical site infection.

    7 weeks for each case

Study Arms (2)

Group A: Active drainage group

SHAM COMPARATOR

use of closed suction drain (18 F Hemovac drain)

Procedure: compare active and passive drain

Group B: Passive drainage group

ACTIVE COMPARATOR

use passive -gravity drainage (22F Penrose drain).

Procedure: compare active and passive drain

Interventions

compare between active drainage and passive drainage in post-operative seroma formation after modified radical mastectomy in in amount ,duration, respiration ,respiration duration ,SSI and skin necrosis

Group A: Active drainage groupGroup B: Passive drainage group

Eligibility Criteria

Sexfemale(Gender-based eligibility)
Gender Eligibility Detailsonly female with breast cancer was enrolled
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Female patient diagnosed with breast carcinoma planned for MRM

You may not qualify if:

  • Previous breast surgery.
  • Active infection.
  • Recurrent or metastatic breast cancer (Stage IV).
  • Un-controlled diabetes mellitus (HbA1C \>7).
  • Coagulopathy disease.
  • Use of anticoagulant or antiplatelet medications.
  • Bilateral breast cancer.
  • Loss to follow-up within one month of drain removal.
  • Pregnancy.
  • Male breast cancer patients.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kafrelsheikh University

Kafr ash Shaykh, Egypt

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
surgical oncology resident at Tanta cancer center

Study Record Dates

First Submitted

May 7, 2026

First Posted

June 2, 2026

Study Start

May 30, 2024

Primary Completion

May 10, 2025

Study Completion

November 15, 2025

Last Updated

June 2, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL

Locations